Recruitment start for the ProTrans study for treatment of COVID-19
ProTrans is given with the aim of reducing hyper-inflammation within the lungs. The goal of the treatment is to shorten hospital stay and time for rehabilitation and save lives.
Svenska- Mon-Fri: 08:30-16:30
- +46 8-735 20 10
- info@cellaviva.se
- Customer Service
